Abbott Laboratories
ABT
#77
Rank
โ‚ฌ182.42 B
Marketcap
104,81ย โ‚ฌ
Share price
-2.39%
Change (1 day)
-2.22%
Change (1 year)
Categories

Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.

Abbott Laboratories (ABT) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ28.25 Billion

According to Abbott Laboratories's latest financial reports the company's total liabilities are โ‚ฌ28.25 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Abbott Laboratories - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ32.20 B3.53%
2023-12-31โ‚ฌ31.10 B-11.1%
2022-12-31โ‚ฌ34.99 B1.16%
2021-12-31โ‚ฌ34.58 B7.58%
2020-12-31โ‚ฌ32.15 B-1.56%
2019-12-31โ‚ฌ32.65 B2.5%
2018-12-31โ‚ฌ31.86 B-15.33%
2017-12-31โ‚ฌ37.63 B23.89%
2016-12-31โ‚ฌ30.37 B66.71%
2015-12-31โ‚ฌ18.21 B13.24%
2014-12-31โ‚ฌ16.08 B25.63%
2013-12-31โ‚ฌ12.80 B-58.09%
2012-12-31โ‚ฌ30.55 B11%
2011-12-31โ‚ฌ27.52 B-3.15%
2010-12-31โ‚ฌ28.42 B37.97%
2009-12-31โ‚ฌ20.60 B15.67%
2008-12-31โ‚ฌ17.81 B18.56%
2007-12-31โ‚ฌ15.02 B-10.4%
2006-12-31โ‚ฌ16.76 B34.88%
2005-12-31โ‚ฌ12.43 B16.77%
2004-12-31โ‚ฌ10.64 B3.37%
2003-12-31โ‚ฌ10.29 B-20.8%
2002-12-31โ‚ฌ13.00 B-19.33%
2001-12-31โ‚ฌ16.12 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ97.47 B 244.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ99.27 B 251.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚ฌ44.52 B 57.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
โ‚ฌ3.40 B-87.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
โ‚ฌ36.77 B 30.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Bristol-Myers Squibb
BMY
โ‚ฌ67.21 B 137.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
โ‚ฌ16.37 B-42.05%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ58.79 B 108.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
โ‚ฌ53.68 B 89.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
โ‚ฌ52.61 B 86.18%๐Ÿ‡ฌ๐Ÿ‡ง UK